We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149 → 175 (+26)

1.34% more ownership

Funds ownership: 24.89% → 26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$6.49M
2
Marshall Wace
Marshall Wace
United Kingdom
+$4.25M
3
Bank of America
Bank of America
North Carolina
+$3.34M
4
GC
GMT Capital
Georgia
+$3.11M
5
SC
Sculptor Capital
New York
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.75M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.49M
3
Stifel Financial
Stifel Financial
Missouri
-$2.45M
4
SG Americas Securities
SG Americas Securities
New York
-$1.25M
5
KAS
Kestra Advisory Services
Texas
-$984K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$1.61M -$275K -10,177 -21%
AllianceBernstein
27
AllianceBernstein
Tennessee
$1.6M – – –
JP Morgan Chase
28
JP Morgan Chase
New York
$1.47M -$560K -20,740 -37%
JG
29
Jefferies Group
New York
$1.45M -$657K -24,310 -41%
Legal & General Group
30
Legal & General Group
United Kingdom
$1.45M +$9.86K +365 +1%
CS
31
Credit Suisse
Switzerland
$1.41M -$111K -4,110 -11%
CAN
32
Cetera Advisor Networks
California
$1.33M +$544K +20,141 +172%
KPWS
33
Kestra Private Wealth Services
Texas
$1.32M – – –
UBS Group
34
UBS Group
Switzerland
$1.28M +$694K +25,685 +518%
UBS AM
35
UBS AM
Illinois
$1.2M -$102K -3,778 -12%
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$1.19M +$768K +28,445 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$1.17M -$758K -28,073 -50%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$1.16M +$25.1K +929 +3%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$1.15M +$972 +36 +0.1%
IFO
40
Intrepid Family Office
Florida
$1.05M – – –
Jane Street
41
Jane Street
New York
$959K +$209K +7,732 +51%
EL
42
Essex LLC
Illinois
$948K +$274K +10,145 +81%
Barclays
43
Barclays
United Kingdom
$901K +$24.4K +902 +4%
CG
44
Cutler Group
California
$886K +$304K +11,240 +113%
Squarepoint
45
Squarepoint
New York
$878K +$567K +20,995 New
MIM
46
MetLife Investment Management
New Jersey
$867K – – –
National Bank of Canada
47
National Bank of Canada
Quebec, Canada
$855K +$545K +20,185 +7,340%
Deutsche Bank
48
Deutsche Bank
Germany
$813K -$116K -4,306 -18%
AIG
49
American International Group
New York
$757K +$6.91K +256 +1%
CSS
50
Cubist Systematic Strategies
Connecticut
$754K +$487K +18,036 New
1
2
3 4 5

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.